Meyhoff T S, Krag M, Hjortrup P B, Perner A, Møller M H
Department of Intensive Care 4131, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Acta Anaesthesiol Scand. 2017 May;61(5):513-522. doi: 10.1111/aas.12878. Epub 2017 Mar 10.
Use of life support in intensive care unit (ICU) patients has been associated with increased risk of poor outcome. The prognostic importance of the duration of support is less studied. We assessed the use of life support and the association between its duration and 90-day mortality in a contemporary cohort of acutely admitted adult ICU patients.
We performed a post-hoc analysis of the SUP-ICU 7-day inception cohort study (n = 1034), which was conducted in 97 ICUs in 11 countries. We included patients with an ICU stay of 3 days or more. We assessed the use of life support during the first 3 days in ICU and the crude and adjusted association between its duration and 90-day mortality using logistic regression analyses.
We included 690 patients; their 90-day mortality was 23%. During the first 3 days in ICU mechanical ventilation was used in 65%, vasopressors/inotropes in 57% and renal replacement therapy in 13%. Renal replacement therapy for 3 days or more was associated with a higher 90-day mortality as compared with 1 day of renal replacement therapy [odds ratio 6.5 (95% confidence interval 1.3 to 32.8)]. For mechanical ventilation and vasopressors/inotropes the odds ratios were 2.2 [0.9 to 5.3] and 1.2 [0.5 to 2.6], respectively.
Among acutely admitted adult ICU patients, a higher number of days of renal replacement therapy in the initial ICU stay were associated with increased risk of death within 90 days. We did not observe such an association for mechanical ventilation or vasopressor/inotropic therapy.
在重症监护病房(ICU)患者中使用生命支持与不良预后风险增加相关。支持时间的预后重要性研究较少。我们评估了急性收治的成年ICU患者当代队列中生命支持的使用情况及其持续时间与90天死亡率之间的关联。
我们对在11个国家的97个ICU中进行的SUP-ICU 7天起始队列研究(n = 1034)进行了事后分析。我们纳入了ICU住院3天或更长时间的患者。我们评估了ICU前3天生命支持的使用情况,以及使用逻辑回归分析其持续时间与90天死亡率之间的粗略和校正关联。
我们纳入了690名患者;他们的90天死亡率为23%。在ICU的前3天,65%的患者使用了机械通气,57%的患者使用了血管升压药/正性肌力药,13%的患者使用了肾脏替代治疗。与进行1天肾脏替代治疗相比,进行3天或更长时间的肾脏替代治疗与更高的90天死亡率相关[比值比6.5(95%置信区间1.3至32.8)]。对于机械通气和血管升压药/正性肌力药,比值比分别为2.2[0.9至5.3]和1.2[0.5至